套细胞淋巴瘤患者合并症与死因的性别差异:全国人群队列研究
该全国人群队列纳入2000-2014年诊断的1385例套细胞淋巴瘤患者(男性1009例,女性376例,中位年龄71岁)。44%存在任何合并症(CCI≥1),28%为重合并症(CCI≥2)。女性有任何合并症时非淋巴瘤死亡占比高于男性。
要点
- 重合并症(CCI≥2)独立增加全因死亡和淋巴瘤特异性死亡风险。
- 结缔组织病、肾病、精神疾病和痴呆患者的风险尤其突出。
- 女性有任何合并症时非淋巴瘤死亡占比更大,或可更倾向观察等待。
核心结论
- 重合并症独立关联套细胞淋巴瘤患者更高的全因死亡和淋巴瘤特异性死亡风险。
- 女性有任何合并症时非淋巴瘤死亡占全部死亡的比例高于男性。
研究设计与样本
- 全国人群-based队列研究,纳入2000-2014年诊断的1385例套细胞淋巴瘤患者(男性1009例,女性376例,中位年龄71岁,范围22-96岁)。
主要发现
- 44%患者有任何合并症(CCI 1+),28%有重合并症(CCI 2+)。
- 随访期间633例(46%)死亡,其中76%死于淋巴瘤。
- 结缔组织病、肾病、精神疾病和痴呆患者的风险尤其突出。
- 女性有任何合并症时,非淋巴瘤死亡占全部死亡的比例高于男性有任何合并症时。
临床怎么用
- 对重合并症患者仍应考虑更有效的淋巴瘤治疗。
- 女性有任何合并症时非淋巴瘤死亡可能性仍可观,或可更宽松地采用观察等待策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prognosis for mantle cell lymphoma (MCL) remains poor. Our aim was to assess the impact of comorbidities on survival and causes of death. For 1,385 MCL patients (1,009 males, 376 females) diagnosed in 2000-2014 (median age 71 years, range 22-96) comorbidities ≤ 10 years of diagnosis were classified according to the Charlson comorbidity index (CCI; 0, 1, 2+). Hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated to compare lymphoma-specific and all-cause mortality rates. Model-based predictions were used to obtain probabilities of death. Overall, 44% had any comorbidity (CCI 1+) and 28% severe comorbidity (CCI 2+). Over a median follow-up of 3·7 years (range 0-16), 633 (46%) died, the majority (76%) from lymphoma. Severe comorbidity was independently associated with higher all-cause [hazard ratio (HR) = 1·52; 95% CI: 1·24-1·85) and lymphoma-specific mortality (HR = 1·31; 95% CI: 1·04-1·65). Particularly among patients with connective tissue, renal and psychiatric diseases, and dementia. Among females with any comorbidity, non-lymphoma deaths represented a larger proportion of all deaths, compared to males with any comorbidity. In general, more efficient lymphoma treatments need to be considered also for patients with severe comorbidity. However, among females with any comorbidity, the likelihood of non-lymphoma death was still considerable, perhaps favouring a more liberal use of a "wait and watch" approach.
引用
- Glimelius I, Smedby KE, Eloranta S, et al. Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study. Br J Haematol. 2019. PMID: 31721156. doi:10.1111/bjh.16317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。